Skip to main content
Premium Trial:

Request an Annual Quote

To Boost Women

In a new policy statement, China's Ministry of Science and Technology says it will be giving priority to female researchers in recruitment and funding decisions, the South China Morning Post reports. It adds that the policy further will loosen age limits for talent programs and provide extra time on research projects for female researchers who had been on maternity leave.

According to SCMP, 49 percent of all individuals with college degrees in China are women, but a much smaller percentage are academicians. It adds that 6 percent of academicians at the Chinese Academy of Sciences and 5.3 percent of academicians at the Chinese Academy of Engineering are women. It further notes that Tu Youyou, a traditional Chinese medicine specialist who won the 2015 Nobel Prize for her work contributing to a malaria therapy, has been unable to garner the "academician" title despite multiple attempts.

The new policy statement says that more women should be nominated as academicians and, provided they are as qualified as male nominees, they should be approved first, it adds.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.